Trial site
The Indiana Clinical Trials Center
- 6running trials
- 8closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria5 trials
- Atopic dermatitis (eczema)4 trials
- Psoriasis3 trials
- Hidradenitis suppurativa1 trial
- Phase
- Phase 39 trials
- Phase 25 trials
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Terminated1 trial
- Lead sponsor
- Alumis Inc2 trials
- Novartis Pharmaceuticals2 trials
- Acrotech Biopharma Inc.1 trial
- Bluefin Biomedicine, Inc.1 trial
- Blueprint Medicines Corporation1 trial
- and 7 more
Running trials
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Active, not recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Closed trials
Completed
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
Completed
Terminated
Completed
Completed
The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026